0.84
-0.0422 (-4.78%)
-0.0422 (-4.78%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Advaxis Inc | ADXS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.0422 | -4.78% | 0.84 | 19:04:15 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.8772 | 0.8204 | 0.8879 | 0.8299 | 0.8822 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.83 | 0.84 | 0.01 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,744 | 4,410,216 | $ 0.8603749 | $ 3,794,439 | 14,330,201 | 0.2645 - 1.57 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:06:57 | 99 | $ 0.84 | USD |
Advaxis Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 92.25M | 109.82M | 109.76M | $ 20.88M | $ - | 0.02 | -1.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Advaxis News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ADXS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.9615 | 1.06 | 0.690201 | 0.9045324 | 9,728,127 | -0.1215 | -12.64% |
| 1 Month | 0.733 | 1.57 | 0.6901 | 1.08 | 16,826,233 | 0.107 | 14.6% |
| 3 Months | 0.32 | 1.57 | 0.2941 | 0.7669832 | 14,398,410 | 0.52 | 162.5% |
| 6 Months | 0.4695 | 1.57 | 0.2645 | 0.6698899 | 8,633,122 | 0.3705 | 78.91% |
| 1 Year | 0.80 | 1.57 | 0.2645 | 0.665876 | 4,899,709 | 0.04 | 5.0% |
| 3 Years | 1.86 | 10.80 | 0.181 | 0.7434114 | 3,414,417 | -1.02 | -54.84% |
| 5 Years | 6.22 | 16.295 | 0.181 | 1.66 | 2,377,415 | -5.38 | -86.5% |
Advaxis Description
| Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology which utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate Specific Antigen (PSA) associated with prostate cancer. |
